Key result
Anticoagulant drugs are advancing in clinical application and development for thromboembolic disease, alongside evolving market trends in China and globally.
This review provides an overview of the epidemiology of thromboembolic disease and the development and market analysis of anticoagulant drugs.
Answers are grounded in this paper and cite their sources.
New anticoagulants require cautious clinician awareness in thromboembolic disease; extends review of advancements but leaves optimal integration open.
This review describes epidemiology of thromboembolic disease in China and abroad, evaluates trends in the development of anticoagulant drugs, and analyzes the market situation based on large amounts of accumulated data. Specifically, we describe advances in clinical application of anticoagulants and analyze the most commonly used anticoagulants in the market systematically.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2018) studied this question. Anticoagulant drugs are advancing in clinical application and development for thromboembolic disease, alongside evolving market trends in China and globally.
Synapse has enriched 10 related papers. Consider them for comparative context: